tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ionis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
PremiumThe FlyIonis Pharmaceuticals announces CHMP opinion recommending Dawnzera approval
22d ago
Arrowhead price target raised to $45 from $29 at Morgan Stanley
Premium
The Fly
Arrowhead price target raised to $45 from $29 at Morgan Stanley
24d ago
Ionis Pharmaceuticals announces $700M convertible senior notes offering
Premium
The Fly
Ionis Pharmaceuticals announces $700M convertible senior notes offering
25d ago
Ionis Pharmaceuticals announces Phase 3 CORE, CORE2 met primary endpoint
PremiumThe FlyIonis Pharmaceuticals announces Phase 3 CORE, CORE2 met primary endpoint
27d ago
Cathie Wood Buys the Dip in Archer Aviation (ACHR) After Weak Q3 Results, Trims Stakes in Roku and TER Stocks
Premium
Market News
Cathie Wood Buys the Dip in Archer Aviation (ACHR) After Weak Q3 Results, Trims Stakes in Roku and TER Stocks
29d ago
Ionis Pharmaceuticals presents data on Dawnzera at ACAAI 2025 Annual Meeting
Premium
The Fly
Ionis Pharmaceuticals presents data on Dawnzera at ACAAI 2025 Annual Meeting
1M ago
Ionis Pharmaceuticals price target raised to $99 from $59 at TD Cowen
PremiumThe FlyIonis Pharmaceuticals price target raised to $99 from $59 at TD Cowen
1M ago
Ionis Pharmaceuticals: Strong Q3 Performance and Promising Future Catalysts Support Buy Rating
Premium
Ratings
Ionis Pharmaceuticals: Strong Q3 Performance and Promising Future Catalysts Support Buy Rating
1M ago
Ionis Pharmaceuticals price target raised to $95 from $80 at Barclays
Premium
The Fly
Ionis Pharmaceuticals price target raised to $95 from $80 at Barclays
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100